Evidence map›Paper›PMID 37250894›Full record

ArticleFrontiers in cell and developmental biology2023

Metformin impairs trophoblast metabolism and differentiation in a dose-dependent manner.

Sereen K Nashif, Renee M Mahr, Snehalata Jena, Seokwon Jo, Alisa B Nelson, Danielle Sadowski, Peter A Crawford, Patrycja Puchalska, Emilyn U Alejandro, Micah D Gearhart and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Repurposing metformin for choriocarcinoma: targeting the AMPK/mTOR pathway.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. [Metformin ameliorates PM2.5-induced functional impairment of placental trophoblasts by inhibiting ferroptosis].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2024
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Sereen K NashifDepartment of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, United States.
Renee M MahrDepartment of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, United States.
Snehalata JenaDepartment of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, United States.
Seokwon JoDepartment of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, United States.
Alisa B NelsonDivision of Molecular Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, United States.
Danielle SadowskiDepartment of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, United States.
Peter A CrawfordDivision of Molecular Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, United States.
Patrycja PuchalskaDivision of Molecular Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, United States.
Emilyn U AlejandroDepartment of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, United States.
Micah D GearhartDepartment of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, United States.
Sarah A WernimontDepartment of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, United States.
University of Minnesota · USUniversity of Minnesota Medical Center · US

Funding

REPRODUCTIVE SCIENTIST TRAINING PROGRAMK12HD000849 · NICHD · WASHINGTON UNIVERSITY · PI Danny J Schust · 1988 to 2026
$33.2M
KETONE BODY METABOLISM AND INTEGRATED METABOLIC HOMEOSTASISR01DK091538 · NIDDK · WASHINGTON UNIVERSITY · PI CRAWFORD, PETER A · 2011 to 2024
$6.2M
Ketogenic Oscillations and Neurometabolic HealthspanR01AG069781 · NIA · UNIVERSITY OF MINNESOTA · PI CRAWFORD, PETER A, THYFAULT, JOHN P · 2020 to 2024
$2.3M
Placental Insulin Signaling and mTOR Nutrient-Sensing Programming of Offspring Metabolic HealthR01DK136237 · NIDDK · UNIVERSITY OF MINNESOTA · PI Emilyn Alejandro · 2023 to 2026
$2.2M
Epigenetic Control of Human Trophoblast Stem Cell DifferentiationR21HD102770 · NICHD · UNIVERSITY OF MINNESOTA · PI GEARHART, MICAH · 2020 to 2021
$425k
Regulation of Autophagy-driven Pancreatic Beta Cell Function by Nutrient Sensor ProteinsF31DK131860 · NIDDK · UNIVERSITY OF MINNESOTA · PI JO, SEOKWON · 2022 to 2024
$101k
Placental Insulin Signaling and mTOR Nutrient-Sensing Programming of Offspring Metabolic HealthR56DK131447 · NIDDK · UNIVERSITY OF MINNESOTA · PI ALEJANDRO, EMILYN · 2022 to 2022
$93k
NIA NIH HHS R01 AG069781NICHD NIH HHS K12 HD000849NICHD NIH HHS R21 HD102770NIDDK NIH HHS F31 DK131860NIDDK NIH HHS R01 DK091538NIDDK NIH HHS R01 DK136237NIDDK NIH HHS R56 DK131447
6 · The paper itself

Abstract

Metformin is a widely prescribed medication whose mechanism of action is not completely defined and whose role in gestational diabetes management remains controversial. In addition to increasing the risk of fetal growth abnormalities and preeclampsia, gestational diabetes is associated with abnormalities in placental development including impairments in trophoblast differentiation. Given that metformin impacts cellular differentiation events in other systems, we assessed metformin's impact on trophoblast metabolism and differentiation. Using established cell culture models of trophoblast differentiation, oxygen consumption rates and relative metabolite abundance were determined following 200 µM (therapeutic range) and 2000 µM (supra-therapeutic range) metformin treatment using Seahorse and mass-spectrometry approaches. While no differences in oxygen consumption rates or relative metabolite abundance were detected between vehicle and 200 µM metformin-treated cells, 2000 µM metformin impaired oxidative metabolism and increased the abundance of lactate and TCA cycle intermediates,

Indexed as

BeWocytotrophoblastdifferentiationmetabolismmetforminmitochondriasyncytiotrophoblasttrophoblast stem cell

Identifiers

PMID37250894
PMCPMC10213689
OpenAlexW4376279813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.